Skip to content
WealthTicker
Back to screener
EquitySectoral/ ThematicDirectGrowthVery High
UTI logo

UTI - Healthcare Fund

UTI Mutual Fund · Best Sectoral & Thematic Mutual Funds

NAV
₹398.73
+0.41% 1D
as of 19 Nov 2026

Performance

+22.03%absolute
52-week rangePrev NAV ₹397.08
Latest ₹398.73
Low ₹304.4898th percentile of its 52-week rangeHigh ₹400.84

Scorecard

★★★★☆4/5 vs 145 of 257 Sectoral/ Thematic peers
  • Performance 60%
  • Risk 15%
  • Cost 10%
  • Downside 15%
How this is computed

Each verdict is computed from this fund's own metrics against its sub-category — the number behind it is shown, not a black-box rating. The stars weight the same ground 60/15/10/15 (performance/risk/cost/downside) across every fund in the peer group. Ranked within Sectoral/ Thematic (same plan and option). 145 of the 257 Sectoral/ Thematic funds in this cohort carry the full record the stars need, so they are the ones ranked against.

PerformanceStrong

3Y CAGR +23.08% · ranks 8 of 145 Sectoral/ Thematic funds

RiskLow

Volatility 13.7% vs 15.8% category avg

CostAverage

1.4% expense vs 1.3% category avg

ConsistencyModerate

83% of rolling 3Y windows were positive

Strengths & concerns

Generated from this fund's own numbers against its sub-category — each point names the figure behind it.

Strengths

  • Ahead of the Sectoral/ Thematic average on 1M/3M/6M/1Y — 1Y by 16.35pp
  • 3-year return (+23.08%) beats the Sectoral/ Thematic average (+14.28%)
  • 5-year return (+17.75%) beats the Sectoral/ Thematic average (+12.96%)
  • Ranks #11 of 238 on 1-year return in its Sectoral/ Thematic cohort
  • Stronger risk-adjusted returns — Sharpe 1.21 vs 0.48 Sectoral/ Thematic average

Concerns

No significant concerns identified.

Key Metrics

1.35%
Direct 1.35% · Regular 2.23%
Category 1.27%▲0.08%
40.67
Category 29.96▲10.71
1.21
Category 0.48▲0.73

Scheme Info

Definitions
Plan
Direct · Growth
None
Up to 1.00%
tiered — see the full terms
0.005%
SIP Inv.
Allowed
₹500
₹5,000
BSE Healthcare TRI
28 Jun 1999

Period returns (<1Y, absolute — not annualized)

Definitions
+10.51%
+2.79%
+13.20%
+23.98%

Annualized returns (≥1Y — CAGR)

Definitions
+22.03%
+23.08%
+17.75%
+15.89%
+16.53%
Advanced metrics — risk and benchmark ratios

Fund vs category average (Sectoral/ Thematic)

PeriodFundCategory avg.Diff
1M abs+10.51%+6.15%+4.36%
3M abs+2.79%+0.56%+2.23%
6M abs+13.20%+7.94%+5.26%
1Y CAGR+22.03%+5.68%+16.35%
3Y CAGR+23.08%+14.28%+8.80%
5Y CAGR+17.75%+12.96%+4.79%

Category average across peers in Sectoral/ Thematic (up to 257 funds with data), same plan and option, excluding this fund. Under-1-year figures are absolute; 1Y and beyond are annualised (CAGR).

Not sure what a figure means? The glossary explains every metric, and the methodology shows the formulas.

Category rank

Vs 257 peers in Sectoral/ Thematic

1Y return
+22.03%
Beats 95.8% · rank #11 of 238
3Y return
+23.08%
Beats 95.1% · rank #8 of 145
5Y return
+17.75%
Beats 82.9% · rank #19 of 106
Sharpe
1.21
Beats 98.6% · rank #3 of 145
Sortino
1.73
Beats 98.6% · rank #3 of 145

Backtest this fund

What a SIP or one-time investment would have grown to over this fund’s real NAV history.

Period
Invested
₹6.00L
Current value
₹10.30L
Absolute
+71.60%
XIRR
+22.44%
Value vs. invested
ValueInvested

60 monthly installments of ₹10,000 into UTI - Healthcare Fund, valued at the latest NAV. XIRR annualizes for each installment’s timing.

Calendar-year returns

What the fund actually returned in each year, not the smoothed average.

YearFundNifty Healthcare TRIDiff
2026part+23.98%+19.00%+4.98%
2025-2.18%-1.53%-0.65%
2024+44.27%+41.34%+2.93%
2023+39.56%+33.89%+5.67%
2022-11.30%-10.17%-1.13%
2021+20.35%+19.01%+1.34%
2020+68.92%——
2019+2.17%——
2018-6.54%——
2017+7.18%——

January–December, from this fund's NAV history. Absolute return, not annualised. “part” marks a year the fund didn't run end to end — its first year, the current year so far, or one it stopped reporting in; those years show no benchmark comparison.

History points
3,415
Expense ratio
1.35%
AUM
₹1,399Cr
Portfolio turnover
30%
Exit load
1.00% if redeemed before 30 days from the date of allotment. Nil if redeemed on or after 30 days from the date of allotment
P/E ratio
40.7
P/B ratio
7.6
Avg market cap
₹98,360Cr
P/E & P/B are portfolio-weighted harmonic means across 39 of 46 equity holdings (88% of the portfolio); loss-making companies are excluded.

Taxation

Taxed as equity

This is an equity-oriented fund (≥65% in Indian equities), so gains get the concessional capital-gains rates below — they do not add to your income-tax slab.

Short-term (STCG)
20%
Held under 1 year

Flat, on the whole gain

Long-term (LTCG)
12.5%
Held 1 year or more

On gains above ₹1.25 L per financial year

Applies to capital gains on redemption. Excludes IDCW/dividend tax, STT, surcharge and cess, and pre-2018 equity grandfathering. For research only — consult a tax advisor before filing.

Asset allocation

As on 31 Oct 2026 · AMC disclosure
  • Equity97.99%
  • Cash & Equivalents1.99%

Fund size over time

Quarterly average AUM · AMFI
₹1,399Cr
July - September 2026
+29%
since January - March 2026
+₹78.46Cr
est. net flow, last quarter

At or near its largest, ₹1,399Cr in July - September 2026. Size matters most where the mandate is narrow — a large small-cap or a very large flexi-cap book is harder to move without moving the price.

Net flow is an estimate: AMFI publishes a quarterly average AUM, not a closing balance, and it covers every plan and option of this scheme together, so it is a read on direction and rough size rather than a cash-flow statement.

UTI Mutual Fund logo

AMC Profile

UTI Mutual Fund descends from the Unit Trust of India, which was effectively the whole Indian mutual fund industry from 1963 until private managers were allowed in. It was carved out as a SEBI-registered fund house in 2003, is listed on the exchanges, and is held by SBI, LIC, Bank of Baroda, PNB and T. Rowe Price rather than a single parent.

Launched
13 Nov 2002
Total AUM
₹4,02,337Cr+2.5% QoQ
Avg AUM · July - September 2026
Website
utimf.com

Fund Managers

KGKamal GadaStart date not disclosed
Role

Senior Vice President- Equity

Education

B.com, CA, CS, CFA

Experience

He is the Vice President - Equity. He completed CA from ICAI and has cleared Level 3 of CFA from CFA Institute, USA. He graduated in Bachelor of Commerce in 2003 from Mumbai University. He began his career with BPCL as Senior Accounts Officer in 2004. Kamal joined UTI AMC in 2008 as Research Analyst. Presently he is Fund Manager for UTI Healthcare Fund as well as covers Pharma and Chemicals sector. He has over 16 years of experience in Equity Research. May 2025

All schemes Kamal Gada runs →

Fund manager, benchmark and dealing terms from this scheme's SEBI-filed Scheme Information Document on AMFI. Each manager's qualifications and role are reconciled across every filing this fund house makes for them, including its Statement of Additional Information. Total AUM via AMFI.

Returns and risk are computed from NAV history and may differ slightly from other portals due to methodology (rolling vs point-to-point, dividend treatment). For research only — not investment advice.

About Sectoral & Thematic funds

Sectoral and thematic funds must keep at least 80% in the equity of one sector (banking, pharma, technology) or one theme (consumption, manufacturing, ESG). That concentration is the point and the risk: with no mandate to diversify away from the sector, the fund rises and falls with it.

From the blog

Frequently asked questions

What is the NAV of UTI - Healthcare Fund?

As of 19 Nov 2026, the NAV of UTI - Healthcare Fund is ₹398.73 per unit. NAV (net asset value) is the fund's per-unit price, published once each business day.

What returns has UTI - Healthcare Fund delivered?

UTI - Healthcare Fund has returned +22.03% over 1 year, +23.08% per year over 3 years, +17.75% per year over 5 years and +16.53% per year since inception. Figures beyond one year are annualised (CAGR) and are computed from AMFI NAV history, so they may differ slightly from other portals.

What is the expense ratio of UTI - Healthcare Fund?

UTI - Healthcare Fund charges an expense ratio of 1.35% per year. This annual fee is already deducted from the NAV, so the returns you see are net of it.

What are the top holdings of UTI - Healthcare Fund?

UTI - Healthcare Fund's largest holdings are SUN PHARMACEUTICALS INDUSTRIES (7.4%), DIVIS LABORATORIES LTD. (6.5%), DR REDDYS LABORATORIES LTD. (5.8%), AJANTA PHARMA LTD. (4.3%) and MAX HEALTHCARE INSTITUTE LTD (4.2%). Holdings are disclosed monthly and change over time.

How risky is UTI - Healthcare Fund?

UTI - Healthcare Fund sits at the very high level on our estimate of SEBI's risk-o-meter scale, its trailing-3Y volatility (annualised) is 13.7% and its worst peak-to-trough fall in our sample was 27.1%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

What does the Sharpe ratio of 1.21 mean?

The Sharpe ratio is return earned per unit of total risk, above a 6.5% risk-free rate. UTI - Healthcare Fund's 1.21 means it has rewarded its volatility with excess return. Higher is better.

What is the benchmark of UTI - Healthcare Fund?

UTI - Healthcare Fund is benchmarked against the BSE Healthcare TRI. The alpha, beta and capture figures on this page are measured against the Nifty Healthcare TRI, the closest index whose daily history we hold.

Who manages UTI - Healthcare Fund?

UTI - Healthcare Fund is managed by Kamal Gada at UTI.

When was UTI - Healthcare Fund launched, and what is its objective?

UTI - Healthcare Fund was launched on 28 Jun 1999. its stated objective is: The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. Both are as filed in the scheme's own Scheme Summary Document.

How is UTI - Healthcare Fund taxed?

UTI - Healthcare Fund is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.